arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Fortrea Holdings Inc.

FTRE
$19.54 ▼ -0.90 (-4.40%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
20 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
15
Health
Poor
Bearish
auto_awesome

Analytical Summary

Fortrea Holdings Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.9B
Dividend Yield —
Revenue Growth -4.5% ↘
Op. Margin 2.2% ↗
ROIC 10.4% ↗
FCF / Share $0.30 ↗
Trailing P/E —
Price / Book 3.5x
FCF Yield 1.6%
Debt / Equity 1.98
info Valuation on last close. End-of-day price, Sep 23, 2026.

20-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$678.20M
↓ -4.5% —
Net Income Profit after all expenses
$-23.60M
↑ +95.8% —
Operating Margin Operating profit as % of sales
2.2%
↑ +508.5% 7th
FCF / Share Free cash flow per share
$0.30
↑ +267.8% —
Long-Term Debt Long-term obligations
$1.04B
↓ -0.5% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability ↓
18
Returns
4
Financial Health
22
Cash Quality
18

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 20 quarters